Profile avatar
smpage1.bsky.social
3 posts 8 followers 76 following
Getting Started
Posts 6 Comments 2

@atthelimits.bsky.social great meeting at the Royal College of physicians 15/16 Jan. an international hall of fame of speakers

submitted 46 days ago • 0 comments

Trastuzumab-pertuzumab-taxane is the SoC 1️⃣line for metastatic HER2+ breast cancer; yet, taxane may induce neurotoxicity. The EMERALD trial now out in @JCO_ASCO investigated the role of eribulin instead of a taxane in this setting ⬇️ @oncoalert.bsky.social ascopubs.org/doi/10.1200/...

submitted 53 days ago • 0 comments

As a father of a daughter who had a full liver transplant and is a Stage 4 cancer survivor, F these ghouls to the lowest depths of hell.

submitted 73 days ago • 759 comments

These people eliminated 190 million dollars in childhood cancer research money to pay for tax cuts for the wealthiest corporations in human history. I’m a no.

submitted 74 days ago • 813 comments

Adjuvant ribociclib has been approved by EMA for HR+/HER2- early breast cancer, based on the results of NATALEE Industry press release⬇️ @oncoalert.bsky.social www.novartis.com/news/media-r...

submitted 95 days ago • 0 comments

Out in @TheLancetOncol De-escalated neoadjuvant CT with trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer PCR rate 66.3% vs. 57.6% in the nab-paclitaxel group vs. in the docetaxel + carbo group @oncoalert.bsky.social www.thelancet.com/journals/lan...

submitted 96 days ago • 1 comment